ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -92.3% | 10,600 | -75.9% | 0.00% | – |
| Q4 2021 | $26,000 | -43.5% | 43,943 | -9.2% | 0.00% | – |
| Q3 2021 | $46,000 | -25.8% | 48,400 | -27.3% | 0.00% | – |
| Q1 2021 | $62,000 | +72.2% | 66,600 | +136.8% | 0.00% | – |
| Q2 2019 | $36,000 | -53.2% | 28,128 | -22.9% | 0.00% | – |
| Q1 2019 | $77,000 | +40.0% | 36,495 | +41.2% | 0.00% | – |
| Q4 2018 | $55,000 | -78.3% | 25,849 | -64.2% | 0.00% | – |
| Q3 2018 | $253,000 | +3.3% | 72,272 | +3.5% | 0.00% | – |
| Q2 2018 | $245,000 | 0.0% | 69,846 | 0.0% | 0.00% | – |
| Q1 2018 | $245,000 | +0.4% | 69,846 | +26.2% | 0.00% | -100.0% |
| Q4 2017 | $244,000 | -51.2% | 55,343 | -42.2% | 0.00% | 0.0% |
| Q3 2017 | $500,000 | +214.5% | 95,697 | +155.2% | 0.00% | 0.0% |
| Q1 2017 | $159,000 | +45.9% | 37,500 | +9.2% | 0.00% | – |
| Q4 2016 | $109,000 | +17.2% | 34,337 | +20.5% | 0.00% | – |
| Q3 2016 | $93,000 | – | 28,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 292,366 | $283,000 | 0.02% |
| Virtu Financial LLC | 204,870 | $199,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $139,000 | 0.02% |
| Founders Capital Management | 18,000 | $17,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $10,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $22,000 | 0.00% |
| Belvedere Trading LLC | 118,500 | $146,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $13,000 | 0.00% |
| Atom Investors LP | 56,492 | $55,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $21,000 | 0.00% |